针对癌症免疫疗法的精度:通过单细胞测序发现自然发生的抗原特异性TCR
Saleh Alrhmoun1,2, Marina Fisher1, Julia Lopatnikova1
1Laboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, 630099 Novosibirsk, Russia.
Cancers
|December 17, 2024
概括
这项研究提出了一种新的方法来分析T细胞受体 (TCR) 候选人用于TCR-T细胞治疗的全部范围,显著提高了癌症治疗潜力. 该方法确定了针对固体瘤的高效TCR.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 采用细胞疗法,特别是T细胞受体工程T (TCR-T) 细胞疗法,对固体瘤具有前景.
- 目前的TCR-T疗法开发方法提供有限的TCR候选者,可能缺少最佳目标.
研究的目的:
- 开发一种全面的方法来识别自然存在的抗原特异性T细胞受体 (TCRs) 的整个谱.
- 发现和分析TCRs,以增强TCR-T细胞治疗针对固体瘤的开发.
主要方法:
- 扩展的抗原特异性CD8 T淋巴细胞使用以免疫性为原料的树突细胞.
- 通过单细胞RNA测序,TCRscape和ERGO-II神经网络分析了抗原特异性TCRs的全部谱.
- 评估了候选TCR-T细胞的功能性和选择性.
主要成果:
- 实现了抗原特异性T细胞的200倍以上的增加.
- 已经确定了100多种抗原特异性TCR克隆类型.
- 发育的TCR-T细胞表现出高细胞毒性和对抗原的选择性.
结论:
- 该研究提供了一种全面的方法,用于发现和分析用于TCR-T细胞治疗的抗原特异性TCRs的完整目录.
- 该方法具有多功能性,可适应各种抗原和MHC变体,用于研究和临床使用.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.